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Abstract
QUESTIONS UNDER STUDY: In Switzerland, skin can-
cer is one of the most prevalent neoplasms. General prac-
titioners (GPs) are often faced with suspicious skin lesions
in their patients. The aim of our study was to assess GPs’
competence to diagnose skin cancer and to examine wheth-
er this can be improved by a one-day dermatologic educa-
tion programme.
METHODS: Study design: Pre / post-intervention study.
Study population: 78 GPs in the Canton of Zurich. In-
tervention: A one day dermatologic education programme
provided by a dermatologist. Measurements: Before (T0)
and after (T1) the dermatologic education programme, GPs
were asked to rate pictures (with a short history) of skin le-
sions on a visual analogue scale according to their likeli-
hood of malignancy. Analysis: Non-parametric paired Wil-
coxon signed rank test was used to compare the sum score
of correctly classified skin lesions at T0 and T1.
RESULTS: At T0 GPs classified 63.9% lesions correctly
(benign: 51.2%; malignant: 76.6%), while at T1 these fig-
ures increased to 75.1% (benign: 67.6%; malignant:
82.7%).
CONCLUSION: A one-day dermatologic education pro-
gramme led to improvements in GPs’ diagnostic competen-
ce in skin cancer, but there remained room for further im-
provement.
Key words: Skin cancer; general practitioner; melanoma;
non-melanoma skin cancer; dermatology; educational
intervention; diagnosis
Background and questions under
study
Skin cancer is one of the most common neoplasms in
Switzerland [1] and its prevalence is high compared to oth-
er countries in Europe [2–5]. Forsea et al. [6] estimated that
Switzerland has the highest melanoma incidence in Europe
with 19.2 cases per 100,000 residents (compared for ex-
ample with Germany with around 12 cases per 100,000 res-
idents or Austria with under 8 cases per 100,000 residents).
Melanoma is responsible for more than 90% of all skin can-
cer related deaths. The melanoma lifetime risk at birth in
the year 2000 was estimated to be 1:80 in Switzerland [7,
8]. There are currently approximately 1,900 new cases of
melanoma per year in Switzerland [1] and the incidence
continuously increases. Melanoma is the fourth most fre-
quent cancer in Switzerland in men as well as in women
[9]. For men, only prostate cancer, lung/bronchus/trachea
cancer and colorectal cancer have a higher incidence than
melanoma; for women only breast cancer, colorectal cancer
and lung/bronchus/trachea cancer have a higher incidence
than melanoma [9]. Potential determinants of this increase
in Switzerland are the more frequently intermittent sun ex-
posure for fashion [10] and during recreation as well as a
higher detection rate because increasing numbers of nevi
get excised and histologically examined [1, 11].
One third of Swiss patients with melanoma are less than 50
years old: melanoma is one of the most frequent cancer dia-
gnoses in young adults [1]. Due to a lack of adequate ther-
apies for metastatic melanoma, the best management op-
tion remains early diagnosis and prompt surgical excision
of the primary cancer.
Non-melanoma skin cancer (NMSC) including basal cell
carcinoma (BCC) and squamous cell carcinoma (SCC) are
more frequent than melanoma. They are, from a clinical
point of view, less aggressive because of their low meta-
static potential, but due to their high incidence, local de-
structive growth pattern, and their tendency to recur after
treatment, the morbidity and cost related to these cancers
are very high [12].
Due to the rapidly rising incidence of skin cancer and the
rising awareness of the topic in patients, GPs are more
and more faced with suspicious skin lesions in their pa-
tients, they are usually the first contact person to examine
and potentially refer patients to dermatologists. Appropri-
ate knowledge and a high diagnostic competence are cru-
cial in handling suspicious skin lesions correctly. During
medical school there is no specific skin cancer training at
this point in time. Research data on the dermatological dia-
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gnostic competence of GPs in Switzerland is lacking, but
clinical experience suggests that diagnosis of skin cancer in
primary care may be suboptimal. Embedded in an on-going
broader project called “minSKIN” [13] this study aimed to
assess GPs’ competence to diagnose skin cancer and to de-
termine whether it was increased by a one-day dermatolo-
gic education programme.
Design and methods
Study design:
This is a pre / post-intervention study.
Study population:
All of the around 1,000 GPs in the Canton of Zurich [14]
were invited to take part in the study by an advertisement,
by postal letters and information sessions provided by
members of the study centre. Any general practitioner who
provided primary medical care with a workload of at least
20 hours per week, who did not plan to retire or to move
away during the study period was entitled to participate in
the study. Finally, 78 GPs were included in our study. All of
these 78 GPs later joined the RCT called “minSKIN” after
our one day education programme [13]. The participating
GPs did not receive financial compensation.
Intervention: dermatologic education programme
The dermatologic education programme was embedded in
a randomised-controlled study with GPs [13]. The GPs re-
Figure 1
Example of the interpretation (picture with a malignant lesion).
Figure 2
Percentage of correctly classified skin lesions before (T0) and after
(T1) the one-day dermatologic education programme.
ceived a full day dermatologic training course, organised
by a dermatologist of the University Hospital Zurich. This
training contained lectures about current epidemiology of
skin cancer in Switzerland, background information on
melanoma, basal cell carcinoma and squamous cell car-
cinoma, diagnosis and differential diagnosis of skin cancer,
strategies to handle with suspicious skin lesions and inter-
active case discussions for the three main types of skin can-
cer.
Measurements:
For the study, we developed a pool of total 108 case-vign-
ettes of skin lesions with a short history and known histo-
logy (benign: 54; malignant: 54), 36 cases at a high diffi-
culty level, 36 cases at a medium difficulty level and 36 at
a low difficulty level. The benign case-vignettes included
the diagnoses: nevi, dysplastic nevi, seborrhoic keratosis,
angioma and other benign lesions. The malignant case-
vignettes included the diagnoses: BCC, SCC, melanoma,
M. Bowen, keratoacanthoma and other malignant lesions.
The pictures had to be of good quality (in focus etc.) and
the diagnoses had to be histologically proven. They were
randomly chosen from an image collection of the Clinic of
Dermatology at the University Hospital Zurich. The levels
of difficulty were independently defined by two dermatolo-
gists prior to the start of the study.
As primary outcome, we defined the competence in the dia-
gnosis of skin cancer by GPs, measured as the percentage
of correctly classified pictures of skin lesions. Prior to the
start of the study, we randomly allocated 36 of the clinic-
al case-vignettes (12 at each level of difficulty) for each
picture scoring session to assure an equal difficulty of the
sessions. Before (T0) and after (T1) the dermatologic edu-
cation programme, the GPs were asked to rate these pic-
tures of skin lesions according to their likelihood of ma-
lignancy on a visual analogue scale (VAS) with length 100
mm. Visual analogue scales were chosen for measurements
because they are easy to handle and well known in the
study population. Furthermore, they more strongly reflect
diagnostic uncertainty in every day’s clinic than a dicho-
tomous outcome.
Data analysis:
For each level of difficulty, a cut-off on the VAS was
defined prior to analysis in order to dichotomise the GPs’
judgement into correct or false as compared with the his-
tology results. These cut-offs are displayed in table 1, an
example for the interpretation of a malignant lesion picture
and different levels of difficulty is shown in figure 1. We
used a statistical test procedure that took into account de-
pendencies in the data: assessment of 36 pictures per parti-
cipating GP for each moment in time (T0 and T1). For each
of the 78 GPs, we summed up the number of “correctly”
classified skin lesion pictures according to the above de-
scribed dichotomisation and obtained a score ranging from
0 (no correctly classified picture) to 36 pictures (all pictures
correctly classified), at time T0 and T1. We then compared
these two vectors of length 78 with a non-parametric paired
Wilcoxon signed rank test. Significance level was set at
5%. For descriptive measures, we call “sensitivity” the ma-
lignant lesions (“disease”) that were correctly classified as
Original article Swiss Med Wkly. 2013;143:w13834
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malignant and “specificity” the benign lesions (“no dis-
ease”) that were correctly classified as benign.
Ethical principles
The study was embedded in a broader project called
“minSKIN” [13], which was approved by the ethics com-
mittee of Zurich (KEK-ZH-Nr. 2010-0384/5) and which
has been registered at a trial register (current-controlled-tri-
als: ISRCTN29854485).
Results
Main results
Before the dermatologic education program (at T0) GPs
classified total 63.9% of the lesions correctly (51.2% of be-
nign lesions and 76.6% of malignant lesions). After the der-
matologic education program (at T1) corresponding values
significantly increased to total 75.1% (67.6% for benign le-
sions and 82.7% for malignant lesions).
Participants
Due to the high interest from the GPs during recruitment,
more than the initially planned number of 60 GPs wanted to
take part in the study, so we were finally able to include 78
GPs. All GPs completed the pre-intervention picture scor-
ing session at T0 as well as the post-intervention picture
scoring session at T1. One GP did not provide informa-
tion about his or her demographic data. The mean age of
the participating GPs was 50.9 years with a range from
34 to 75 years. As shown in table 2, 71.8% of the GPs
were male and 28.2% female. 55.8% worked fulltime while
Figure 3
Outcomes by the difficulty level of the pictures and without the pre-
defined cut-offs.
44.2% worked part-time. 31.2% worked in a single handed
practice, 26.0% in a double handed practice and 42.9% in
a group practice with three or more physicians. 18.2% of
the participating GPs stated that they have had addition-
al dermatologic training while 81.8% did not. Compared
to all GPs in the Canton of Zurich [14], our study popula-
tion was slightly younger. Furthermore, we had rather more
male GPs in the study population compared to all GPs in
the Canton of Zurich.
Results from the picture scoring sessions
As shown in figure 2, GPs classified 51.2% of benign and
76.6% of malignant lesions correctly before any interven-
tion (at T0). After the dermatologic education programme
(at T1) GPs classified 67.6% of benign and 82.7% of ma-
lignant lesions correctly. The increase in the percentage
points of correctly classified skin lesions was 16.4% for
benign lesions and 6.1% for malignant lesions. With our
dermatologic education programme, GPs’ sensitivity in-
creased from 76.6% to 82.7% without any loss in speci-
ficity.
We calculated the sum score as number of correctly clas-
sified pictures per participating GP before and after the in-
tervention. The paired Wilcoxon signed rank test showed a
significant increase of the sum score after the intervention
(p <0.001).
It could be argued that the cut-offs based on the pre-speci-
fied levels of difficulty were arbitrary. In a secondary ana-
lysis we re-evaluated the outcome of the participating GPs
with respect to difficulty level of the pictures and without
the pre-defined cut-offs, the results can be found in figure
3. It turns out that with increasing level of difficulty, the
mean outcome clearly deviates further from 100 for the ma-
lignant pictures. For benign pictures, the increasing devi-
ation from 0 was clear at T0 but inconsistent at T1. Cor-
responding interquartile ranges increase for both malignant
pictures at T0 and T1 and benign pictures at T0 with in-
creasing difficulty, indicating increasing uncertainty of the
participants. These findings support and justify our original
assumptions.
As also shown in figure 3, the mean VAS values shift from
T0 to T1 nearer to 100 (for malignant lesions) or nearer
to 0 respectively (for benign lesions) and the interquartile
ranges were reduced (except for low difficulty benign le-
sions) from T0 to T1.
Discussion
The diagnostic competence of the GPs’ in our study was
relatively high at baseline, compared to GPs in other stud-
ies [15–21]. Nevertheless, after our one-day dermatologic
education programme, the GPs significantly increased their
Table 1: Cut-offs on the VAS, depending on the difficulty of the pictures.
Picture category Cut-off on the VAS
Malignant lesion, high level of difficulty 70 mm
Malignant lesion, medium level of difficulty 75 mm
Malignant lesion, low level of difficulty 80 mm
Benign lesion, high level of difficulty 30 mm
Benign lesion, medium level of difficulty 25 mm
Benign lesion, low level of difficulty 20 mm
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diagnostic competence in skin cancer regarding lesions’
dignity.
At baseline, GPs scored a higher proportion of malignant
lesions correctly than benign lesions. This may reflect a
GPs’ “fear of missing” of a suspicious skin lesion. From a
clinical point of view it is less severe to overrate a benign
lesion as malignant than to underrate a malignant lesion
as benign because of the lack of therapeutic options for a
metastatic melanoma for example. On the other hand, in-
adequate diagnosis of benign lesions may increase distress
in patients and use of healthcare services at the expense
of other, clinically potentially more effective services. It is
therefore also important to reduce the number of inappro-
priately diagnosed benign skin lesions. The effect of our
dermatologic education programme demonstrated a higher
impact when diagnosing benign lesions as compared to ma-
lignant lesions, implying that it is feasible to enhance dia-
gnostic competence.
In figure 3, the shift of the mean VAS values from T0 to
T1 displayed the effect of our dermatologic education pro-
gramme on the GPs’ diagnostic competence. The reduc-
tion of the interquartile ranges from T0 to T1 may indicate
an increasing dermatological diagnostic security in the par-
ticipating physicians. This reduction can especially been
seen in two subgroups: benign lesions at a medium diffi-
culty level and benign lesions at a high difficulty level. This
may indicate that a dermatologic education programme
could lead to a reduction of unnecessarily removed benign
skin lesions without affecting the removal rate of malignant
skin lesions. A reduction of unnecessarily removed benign
skin lesions can have a considerable impact on health care
costs.
Because the recruiting procedure was done partially by an
advertisement in a GP journal, we are not able to give a
numerical amount of the response rate. However, the GPs’
interest to participate in this study was considerably higher
than in our previous comparable projects. Due to this high
interest, we were able to include many more GPs than ini-
tially planned. From our point of view, this interest shows
the importance and frequency of patients with suspicious
skin lesions in daily practice and the GPs’ relative uncer-
tainty on how to handle all these patients. During their vo-
cational training, most of the GPs did not attend further
dermatological training until now, because it was almost
impossible to get short-term positions in a dermatological
institution as GP trainee.
Limitations and strengths
With this study setting, we were not able to evaluate the
long-term effect of our intervention. Because we did not
ask for specific diagnoses but for their likelihood of ma-
lignancy, it may be that GPs’ diagnostic competence was
overestimated. Nevertheless, from the clinical point of
view, the very specific diagnosis is less important for the
GP because he acts mainly as first contact person for fur-
ther referral. Furthermore, the pool of our case-vignettes
did not reflect the distribution of malignant skin cancer in
primary care, so the pre-test probability for a malignant le-
sion in our study was much higher than in “real life”. As
an additional weakness, we did not ask for the clinical pro-
cedure (excision yes/no) of the lesions, but just for their
likelihood of malignancy. Aside from these limitations, we
had a relatively high number of GPs participating in this
study. Furthermore, by discriminating the skin cancer ex-
ample cases into three levels of difficulty, we used a very
advanced approach in the picture scoring session, consider-
ing the heterogeneity of skin lesions.
Conclusion
With a one-day dermatologic education programme, GPs’
diagnostic competence in skin cancer can be significantly
increased. Taking into account the high interest of GPs in
the topic and considering the effect of our intervention,
skin cancer diagnostic skills should be integrated more of-
ten into GPs’ continuing medical education.
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Gender (n = 78)
Male
Female
56 (71.8%)
22 (28.2%)
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9 (11.7%)
29 (37.7%)
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Years in practice (n = 77)
<= 10 years
11–20 years
>= 21 years
35 (45.5%)
21 (27.3%)
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Group practice
24 (31.2%)
20 (26.0%)
33 (42.9%)
Additional training in Dermatology (n = 77)
Yes
No
14 (18.2%)
63 (81.8%)
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Figures (large format)
Figure 1
Example of the interpretation (picture with a malignant lesion).
Figure 2
Percentage of correctly classified skin lesions before (T0) and after (T1) the one-day dermatologic education programme.
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Figure 3
Outcomes by the difficulty level of the pictures and without the pre-defined cut-offs.
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